The Eicosanoid Research Division: Phospholipase A2, lipid signaling and lipidomics in innate immunity and Inflammation by Balsinde, Jesús
 1 
The Eicosanoid Research Division: 
Phospholipase A2, Lipid Signaling and Lipidomics  
in Innate Immunity and Inflammation* 
 
Jesús Balsinde 
Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC), 47003 Valladolid, 
Spain, and  Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas 
(CIBERDEM), 08017 Barcelona, Spain 
*http://www.balsinde.org  
December 10, 2013 
 
 
There is some discrepancy as to what is really the 
kick-off date of the Eicosanoid Research Division (or 
the Eicosanoid Laboratory, as it came to be known 
first). Truth be told, the thing took its first official 
steps in September 2000, with my definitive arrival 
in Valladolid. Beginnings are always difficult, and 
mine in the old capital of Castile was no exception. 
Because of this and a few other things, the details of 
which I will spare the reader, I usually like to set the 
beginning of our scientific adventures in Castile just 
one year after, in the fall of 2001, which is when 
something resembling a lab was finally put at my 
disposal and a few people were around to start the 
journey along. Our subject matter, obviously lipids 
and all things lipids. Why always lipids?, you may 
ask. Good question. For the moment being, let’s just 
say that lipids play fundamental roles in the 
regulation of cell signaling, and that imbalances in 
lipids and lipid-mediated signaling cause a large 
number of diseases, including type 2 diabetes, 
Alzheimer, arthritis and atherosclerosis. With that in 
mind, it should become obvious that one of the first 
steps we have to take in the direction of curing these 
diseases is to identify the lipids that are involved and 
what they specifically do. 
Many signaling lipids are generated by phospholipases 
such as phospholipase A2, which produces lysophos-
pholipids and free fatty acids like arachidonic acid. 
Further, many of the enzymes involved in the de novo 
pathways of lipid biosynthesis are also implicated in 
signaling. While our long-term goals include a 
comprehensive characterization of the roles played by 
both biosynthesis and remodeling pathways to overall 
cell signaling, our current research focuses primarily on 
the enzymes involved in the maintenance of the 
composition and levels of different fatty acids in 
biological membranes, i.e. phospholipases and acyl-
transferases. In our laboratory we combine a range of 
chemical, biochemical, pharmacological, and molecular 
cell biology techniques to study lipid metabolism and 
signaling in physiology and pathophysiology. Within 
this context, our current goals can be summarized into 
four points, which are described below. (This report 
covers the research activities of our lab from the 
beginning until December 2013). 
 
(1) Cellular regulation of phospholipase A2. 
Phospholipase A2 enzymes catalyze a key reaction in 
signaling, i.e. the release of arachidonic acid and other 
polyunsaturated fatty acids from the sn-2 position of 
cellular glycerophospholipids. The products of phos-
pholipase A2 action, free fatty acids and lysophos-
pholipids may act as signaling molecules on their own, 
and also serve as a precursors for the synthesis of 
platelet-activating factor or the eicosanoids. Our group 
has a long history in studying the mechanisms of 
regulation of phospholipase A2 in resting and stimulated 
cells (reviews: 1-5). Our recent work has highlighted the 
differential contribution of various phospholipase A2s to 
the formation of cellular lysophospholipid pools, and the 
important role that group VIA phospholipase A2 plays in 
this process (6-8). This latter enzyme appears to serve 
multiple roles in cells, and delineating some of these has 
been the subject of our studies Specifically, we have 
studied the involvement of group VIA phospholipase A2 
in modulating lysozyme secretion as well as its various 
roles in cell proliferation and apoptosis (9-12). 
Subcellular localization studies of the various phospho-
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lipase A2 forms have also been conducted (13, 14), and 
various determinants and signaling events that regulate 
the subcellular localization of the arachidonate-specific 
group IVA cytosolic phospholipase A2 have been 
described in detail. Among these, we have unveiled the 
role of a cationic cluster present in the catalytic domain 
of the protein in regulating membrane binding via 
interaction with anionic phospholipids. The involvement 
of phosphorylation reactions in regulating binding of the 
enzyme to phagosomes has been characterized as well 
(15-18). 
 
(2) Signaling mechanisms involved in the bio-
synthesis of eicosanoids by cells of the immune 
system.  
The eicosanoids are a large family of bioactive 
mediators that derive from the enzymatic oxygenation  
of arachidonic acid. The eicosanoids  are biomedically 
important because they mediate all four signs of 
inflammation, namely heat, redness, swelling and pain. 
Controlling the formation of eicosanoids has been found 
to be of great benefit for the treatment of acute and 
chronic inflammatory diseases. Recently, we have 
characterized extensively the differences in arachidonate 
mobilization and eicosanoid metabolism by agonists 
acting via Toll-like receptors (19-22). Overall, our 
results provide support to a model whereby secreted 
group V phospholipase A2 may contribute to the 
eicosanoid biosynthetic response in some cases, by 
increasing activation of group VIA cytosolic phospho-
lipase A2 through amplification of phosphorylation 
cascades. These studies are being extended to agonists 
acting via other innate immune receptors, and also to the 
responses elicited by free fatty acids (23-25). 
 
(3) Membrane fatty acid metabolism; incorporation 
into phospholipids and remodeling.  
The distribution of polyunsaturated fatty acids in cells is 
achieved by a finely regulated set of reactions of 
incorporation, remodeling and liberation of the fatty 
acids into, among and from phospholipids, respectively. 
These reactions ensure the proper distribution of the 
fatty acids within the various cellular phospholipid 
pools, which is important not only for membrane 
homeostasis but also for the execution of appropriate 
cell responses during physiological and patho-
physiological activation. Our current work pays special 
attention to the interactions between omega-3 and 
omega-6 fatty acids, due to their importance as 
precursors of a large number of bioactive substances. 
Members of these two fatty acid families compete with 
each other for incorporation into the sn-2 position of 
membrane glycerophospholipids, which provides a 
control point for regulating their cellular levels, and 
hence the amount of oxygenated products generated 
after stimulation. Our work has led to the discovery of 
the selective involvement of lysophosphatidylcholine 
acyltransferase 3 (LPCAT3) as a novel signal-regulated 
enzyme involved in arachidonic acid metabolism in 
human monocytes (26). Also, inhibition studies of 
phospholipid fatty acid incorporation and remodeling at 
various points have shown elevations of cellular free 
arachidonate levels that alter the balance of eicosanoids 
produced (24) and may also conduce to cell death by 
apoptosis (27). Ongoing studies aim at characterizing at 
the cellular level the different specificities of the CoA-
dependent routes of fatty acid incorporation (acyl-CoA 
synthetases and CoA-dependent acyltransferases), as 
well as the subsequent redistribution of the fatty acids 
into various cellular pools by CoA-independent trans-
acylases (28, 29). Collectively, our research in this area 
supports the concept that differential stimulation of 
phagocytic cells promotes selective lipid turnover and, 
therefore, the appearance of specific lipid signatures for 
each activation condition.  
 
(4) Biosynthesis and degradation of lipid droplets 
during cellular activation.  
Lipid droplets are dynamic cytoplasmic structures 
which, among many other things, may function as 
docking platforms for a number of enzymes involved in 
lipid signaling (30). We have recently described the 
regulation of lipid droplet biosynthesis by various 
members of the phospholipase A2 family of enzymes 
(31-33) as well as the differential involvement of 
various lipid metabolic pathways in signal-regulated 
lipid droplet formation under proinflammatory 
conditions). Our most significant results in this area of 
research suggest that phosphorylation activation of 
group IVA phospholipase A2 by multiple kinases drives 
lipid droplet formation in cells possibly by facilitating 
biogenesis of this organelle, not by regulating neutral 
lipid synthesis (34). Current work aims at precisely 
defining the origin of the fatty acids accumulating in 
lipid droplets under a variety of stimulatory conditions 
(i.e. increased de novo fatty acid synthesis versus 
mobilization from membrane phospholipids). 
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(5) Lipidomics and metabolipidomics; identification 
and quantification of cellular lipidomes by mass 
spectrometry.  
The development of mass spectrometry techniques for 
the detection and analysis of lipids at a global scale 
provides us with a unique opportunity to characterize in 
detail the changes occurring in lipid metabolism as a 
consequence of cell activation (Reviews: 35, 36). Since 
multiple lipid metabolic pathways are known to be 
activated via receptor stimulation in cells, one of the 
major goals of our research in this area is to determine 
the origin and identity of the individual phospholipid 
molecular species that are produced under different 
conditions, as a first step to address their biological roles 
in cells. In the context of these studies, we have 
described a number of novel arachidonate-containing 
lipids, the levels of which increase during cell activation 
(37, 38). A remarkable finding from these studies was 
the discovery of the novel molecular species 1,2-
diarachidonoyl-sn-glycero-3-phosphoinositol as a major 
but transient reservoir of arachidonic acid. We are 
currently investigating the regulation of metabolic 
pathways and enzymes involved, as well as possible 
biological processes mediated by this species. Our most 
recent results suggest that the molecule is produced by 
sequential acylation of positions sn-2 and then sn-1 by 
remodeling with arachidonate of a preexisting 
phosphatidylinositol molecule, and could be involved in 
modulating innate immune responses such as superoxide 
anion production or secretion of antimicrobial 
hydrolases (23) 
Other arachidonate-containing lipids have been 
identified in a stimulus- and cell type-dependent 
manner.  A potentially interesting one is 1-palmitoleyl-
2-arachidonoyl-sn-glycero-3-phosphoethanolamine, a 
phospholipid that  is not present in resting monocytes 
but accumulates rapidly under receptor stimulation (38). 
Once again, these studies support the idea that changes 
in lipid content upon activation may be stimulus-
specific, and also that cellular activation includes both 
common and stimulus-specific markers (23, 37, 38). 
Similar work has been initiated with lipids containing 
adrenic acid, the two-carbon elongation product of 
arachidonic acid (39). Our data in this regard suggest  
that significant differences exist between the cellular 
mechanisms regulating the availability of adrenic acid 
and its immediate precursor arachidonic acid that could 
potentially be exploited to design strategies to control 
the production of oxygenated products of both fatty 
acids. We plan on extending these studies to lipids 
containing omega-3 fatty acids.  
Finally, our expertise in lipidomics has made it possible 
for us to interact with other research groups, and these 
interactions have led to collaborative studies that focus 
on the identification of lipid alterations in various 
models of disease, including caveolin-1 deficiency (28, 
40, 41), hypertriglyceridemia (42), alcohol-induced liver 
disease (43), and cancer (44). Several other lipidomic 
analyses are currently being carried out in our laboratory 
under these collaborative agreements.  
 
Future Directions 
As discussed briefly above, one of our near-future goals 
is to extend our lipidomic studies to omega-3 fatty acids. 
We will identify all the cellular lipids that contain 
omega-3 fatty acyl esters and will follow their 
concentrations under innate immune activation 
conditions. These studies should be complemented with 
work utilizing exogenous fatty acids to verify whether 
omega-3 fatty acyl lipid esters undergo time-dependent 
remodeling similar to that of omega-6 fatty acids, and to 
define the newly-formed species that may accumulate 
under the different cell treatments.  
In subsequent work we plan on studying cellular 
signaling that may involve omega-3 fatty acids, to 
define new molecules and lipid pathways with anti-
inflammatory potential. One of these could well be the 
lipin-2-mediated pathway recently described by us (25). 
A second route that we expect to examine in relation to 
omega-3 fatty acid signaling is the phospholipase D 
pathway. After so many years away from the 
phospholipase D field, working again on this enzyme 
(45-48) could rightfully be seen as taking a sentimental 
journey to the past! 
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